These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 1906912

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Markers of endotoxin related leukocyte activation and injury mechanisms.
    Redl H, Schlag G, Bahrami S, Dinges HP, Schade U, Ceska M.
    Prog Clin Biol Res; 1991; 367():83-100. PubMed ID: 1924434
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Release of interleukin-12 in experimental Escherichia coli septic shock in baboons: relation to plasma levels of interleukin-10 and interferon-gamma.
    Jansen PM, van der Pouw Kraan TC, de Jong IW, van Mierlo G, Wijdenes J, Chang AA, Aarden LA, Taylor FB, Hack CE.
    Blood; 1996 Jun 15; 87(12):5144-51. PubMed ID: 8652827
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
    Kuipers B, van der Poll T, Levi M, van Deventer SJ, ten Cate H, Imai Y, Hack CE, ten Cate JW.
    J Immunol; 1994 Mar 01; 152(5):2438-46. PubMed ID: 8133055
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anti-TNF treatment of baboons with sepsis reduces TNF-alpha, IL-6 and IL-8, but not the degree of complement activation.
    Bengtsson A, Redl H, Schlag G, Högåsen K, Götze O, Mollnes TE.
    Scand J Immunol; 1998 Nov 01; 48(5):509-14. PubMed ID: 9822260
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Contribution of interleukin-1 to activation of coagulation and fibrinolysis, neutrophil degranulation, and the release of secretory-type phospholipase A2 in sepsis: studies in nonhuman primates after interleukin-1 alpha administration and during lethal bacteremia.
    Jansen PM, Boermeester MA, Fischer E, de Jong IW, van der Poll T, Moldawer LL, Hack CE, Lowry SF.
    Blood; 1995 Aug 01; 86(3):1027-34. PubMed ID: 7620156
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. IL-8 in septic shock, endotoxemia, and after IL-1 administration.
    Van Zee KJ, DeForge LE, Fischer E, Marano MA, Kenney JS, Remick DG, Lowry SF, Moldawer LL.
    J Immunol; 1991 May 15; 146(10):3478-82. PubMed ID: 2026876
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The release of interleukin-8 during intravenous bolus treatment with interleukin-2.
    Baars JW, Wolbink GJ, Hart MH, Hack CE, Eerenberg-Belmer AJ, Pinedo HM, Wagstaff J.
    Ann Oncol; 1994 Dec 15; 5(10):929-34. PubMed ID: 7696165
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Proinflammatory cytokines increase in sepsis after anti-adhesion molecule therapy.
    Welty-Wolf KE, Carraway MS, Ghio A, Kantrow SP, Huang YC, Piantadosi CA.
    Shock; 2000 May 15; 13(5):404-9. PubMed ID: 10807017
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.